Banner - Collaborative Care Symposium
News
All NewsPractice Management
Media
All VideosExpert InterviewsPodcastsMedical World NewsViewpointsInsightsCase Based Roundtable SeriesCase StudiesCase of the QuarterPractice OwnershipRapid ReadoutVideo SeriesWhat’s Your WhEYE?
Conferences
Conference CoverageConference ListingConference Recaps
Blog
More
Publications
Digital EditionSupplements And Featured PublicationsiTech
Partners
Resources
Job BoardSponsored
CE

Subscribe

  • News
  • Media
  • Conferences
  • Blog
  • Publications
  • Partners
  • Resources
  • Subscribe
  • CE
  • AMD
  • Allergy
  • Blepharitis
  • COVID-19
  • Cataract
  • Comanagement
  • Comprehensive Eye Exams
  • Conjunctivitis
  • Contact Lenses
  • Cornea
  • DME
  • Diabetic Eye Disease
  • Dry Eye
  • Geographic Atrophy
  • Glasses
  • Glaucoma
  • LASIK
  • Lens Technology
  • Lid and Lash
  • Myopia
  • Nutrition
  • OCT
  • Ocular Surface Disease
  • Optic Relief
  • Patient Care
  • Pediatrics
  • Presbyopia
  • Ptosis
  • Refractive Surgery
  • Retina
  • Technology
  • Therapeutic Cataract & Refractive
Spotlight -
Geographic Atrophy|
Myopia
Advertisement

Ella G. Faktorovich, MD

Advertisement

Articles by Ella G. Faktorovich, MD

Peer-reviewed literature answers 3 questions about COVID-19 and conjunctivitis

ByElla G. Faktorovich, MD
August 10th 2020

A look at recent studies informs on incidence, reservoir of virus, and portal of entry

30 years of LASIK

30 years of LASIK

ByElla G. Faktorovich, MD,Mitch Ibach, OD, FAAO
October 12th 2019
Advertisement

Latest Updated Articles

  • Peer-reviewed literature answers 3 questions about COVID-19 and conjunctivitis
    Peer-reviewed literature answers 3 questions about COVID-19 and conjunctivitis

    Published: August 10th 2020 | Updated:

  • 30 years of LASIK
    30 years of LASIK

    Published: October 12th 2019 | Updated:



Advertisement
Advertisement

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

1

Takeaways from this week in optometry: December 1 - December 5

2

Phase 1 trial findings confirm safety and tolerability of Huons’ dry eye therapy

3

The mechanics of presbyopia: From muscle movement to functional vision

4

Majority of US patients with dry eye experience symptoms weekly, survey finds

5

Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD

  • Advertise
  • About Us
  • Editorial
  • Contact Us
  • Job Board
  • Terms & Conditions
  • Privacy
  • Do not sell my Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Ophthalmology Times
  • Modern Retina
  • Optometry Times
  • Ophthalmology Times Europe
Collaborative Care Symposium
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us